Developing companion diagnostics has several associated challenges related to cost, access to samples, and clinical trial recruitment.
Barbara Marino, PhD
Advertisement
Articles by Barbara Marino, PhD
Advertisement
Latest Updated Articles
Patient-Contributed Tumor Genetics Data: A Pathway to Better Drug Development?Published: December 3rd 2014 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5